Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Alcohol Use Disorder and Its Consequences in Iran From 1990 to 2019: Findings From the Global Burden of Disease Study Publisher



Danandeh K1 ; Rasoulian P1 ; Seyedmirzaei H1 ; Mahmoudvand B2 ; Avand Amini B3 ; Samadian F4 ; Ranjbar Pazuki G5 ; Memari AH1 ; Nakhostinansari A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Islamic Azad University, Tehran Medical Branch, Tehran, Iran
  4. 4. Department of Nursing, Faculty of Nursing and Midwifery, Shahid Beheshti Medical University, Tehran, Iran
  5. 5. Iran University of Medical Sciences, Tehran, Iran

Source: Preventive Medicine Reports Published:2024


Abstract

Background: This study aimed to provide an up-to-date evaluation of the burden of alcohol use disorder and its consequences in Iran from 1990 to 2019. Methods: We assessed the burden of alcohol use disorder and its three subsequent disorders, including cirrhosis and other chronic liver diseases, liver cancer, and cardiomyopathy using Global Burden of Disease (GBD) data. We retrieved data on incidence, prevalence, death, Years of Life Lost from mortality (YLL), Years of healthy life Lost due to Disability (YLD), and Disability-Adjusted Life Year (DALY), which is calculated by summing YLL and YLD values, indices, as well as sociodemographic index (SDI) values. Results: Age-standardized DALY rate of alcohol use disorder reduced from 55.5 in 1990 to 41.8 per 100,000 in 2019 (−24.1 %). Similarly, age-standardized DALY rates of cirrhosis due to alcohol use (−28.7 %), liver cancer due to alcohol use (−20.9 %), and alcoholic cardiomyopathy (−36.3 %) decreased in Iran from 1990 to 2019. In 2019, alcohol use disorder had the highest DALY rate among individuals younger than 55 years, while cirrhosis due to alcohol use imposed the greatest burden on those older than 55. After adjusting for the year, SDI was negatively associated with the age-standardized DALY rate of liver cancer due to alcohol use (p < 0.001), positively associated with that of alcoholic cardiomyopathy (p = 0.002), and not significantly associated with the burden of other conditions (p > 0.05). Conclusions: Despite reductions in the age-standardized DALY rate of alcohol use disorders and related consequences among Iranians, they remain a serious public health concern in Iran. © 2024 The Author(s)
Related Docs
View other Related Docs
1. Burden of Substance Use Disorders in the Middle East and North Africa From 1990 to 2019, Balkan Medical Journal (2025)
2. Age- and Sex-Standardized Prevalence of Alcohol Consumption and Its Determinants in the Western Region of Iran, Ilam: A Cross-Sectional Study, BMC Public Health (2024)
3. Burden of Diseases and Injuries Attributable to Alcohol Consumption in the Middle East and North Africa Region, 1990–2019, Scientific Reports (2022)
4. Results From the First Inpatient Alcohol Withdrawal Management Program in Iran: An Observational Study, Alcohol (2020)
5. The Prevalence and Determinants of Alcohol Use in the Adult Population of Tehran: Insights From the Tehran Cohort Study (Tecs), Clinical and Experimental Medicine (2025)
6. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
7. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
8. Alcohol Treatment Systems in Muslim Majority Countries: Case Study of Alcohol Treatment Policy in Iran, International Journal of Drug Policy (2020)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (29)
Bagher Larijani (29)
Other Related Docs
9. Alcohol Consumption Among Iranian Population Based on the Findings of Steps Survey 2021, Scientific Reports (2024)
10. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
11. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
12. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
13. Attributable Disease Burden Related to Low Bone Mineral Density in Iran From 1990 to 2019: Results From the Global Burden of Disease 2019, Archives of Osteoporosis (2022)
14. Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019, Journal of Thoracic Oncology (2021)
15. Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Respiratory Medicine (2021)
16. Burden of Hand Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Journal of Hand Surgery (2023)
17. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
18. Global, Regional, and National Burden of Gout, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2024)
19. Burden of Osteoarthritis in Iran: A National and Subnational Perspective, 1990−2019 Global Burden of Disease Study, Health Science Reports (2025)
20. Burdens of Type 2 Diabetes and Cardiovascular Disease Attributable to Sugar-Sweetened Beverages in 184 Countries, Nature Medicine (2025)
21. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
22. Low Bone Mineral Density, a Neglected Condition in North Africa and Middle East: Estimates From the Global Burden of Disease Study, 1990–2019, Osteoporosis International (2023)
23. Epidemiology of Brain and Other Central Nervous System Cancers in the North Africa and Middle East Region: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, World Neurosurgery (2023)
24. Global Disease Burden Attributed to Low Physical Activity in 204 Countries and Territories From 1990 to 2019: Insights From the Global Burden of Disease 2019 Study, Biology of Sport (2023)
25. Epidemiology of Substance and Opium Use Among Adult Residents of Tehran; a Comprehensive Report From Tehran Cohort Study (Tecs), BMC Psychiatry (2024)
26. Burden of Tension-Type Headache in the Middle East and North Africa Region, 1990-2019, Journal of Headache and Pain (2022)
27. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)
28. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
29. The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019, Journal of Rheumatology (2023)
30. Increasing Burden of Upper-Extremity Fractures in the Middle East and North Africa (Mena): A 30-Year Analysis of the Epidemiology and Causes of Injuries, Journal of Bone and Joint Surgery (2024)
31. Measuring the Availability of Human Resources for Health and Its Relationship to Universal Health Coverage for 204 Countries and Territories From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
32. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
33. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
34. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
35. Global, Regional, and National Burden of Bone Fractures in 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2021)
36. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
37. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, Chest (2022)
38. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)
39. The Association Between Healthy Beverage Index and Psychological Disorders Among Overweight and Obese Women: A Cross-Sectional Study, BMC Women's Health (2022)
40. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
41. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
42. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
43. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
44. Estimating the Burden of Atrial Fibrillation and Atrial Flutter With Projection to 2050 in Iran, Scientific Reports (2024)
45. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
46. Alcohol Use, Alcohol Use Disorder and Heavy Episodic Drinking in the Eastern Mediterranean Region: A Systematic Review, Addiction (2024)
47. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
48. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
49. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
50. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)